The global antiepileptic drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Antiepileptic drugs (AEDs) are commonly known as anticonvulsants or antiseizure drugs. These drugs are used in the treatment of epileptic seizures. Epilepsy is a central neurological disorder that causes brain activity to become abnormal and further causes seizures or periods of unusual behaviour, sensations and sometimes loss of awareness. Additionally, these drugs are also used to stabilize the mood along with the treatment of bipolar disorders or neuropathic pain.

Some major key players in the market include Abbott Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2022, Sun Pharmaceutical Industries Ltd. announced the launch of a range of Brivaracetam dosage forms at an affordable price for epilepsy treatment in India. Additionally, in June 2021, Glenmark Pharma announced the launch of the anti-epileptic drug, Rufinamide tablets in the US market. Furthermore, in March 2021, Alkem Laboratories has announced the launch of Brivasure, an affordable anti-epileptic drug for the treatment of epilepsy in India. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Drug Type

    • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape- Abbott Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Antiepileptic Drugs Market Report by Segment

By Drug Type

• First Generation AEDs

o Phenytoin (Dilantin, Phenytek)

o Carbamazepine (Carbatrol) 

o Oxycarbazepine (Trileptal)

o Valproate (Depakote)

o Others

• Second Generation AEDs

o Lamotrigine (Lamictal) 

o Pregabalin (Lyrica)

o Rufinamide (Banzel/Inovelon)

o Levetiracetam (Keppra)

o Others

Global Antiepileptic Drugs Market Report by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa